Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.40 |
| ▸ | ANPEP | P15144 | 3/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 3/20 | 0.33 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2802696 | 0.90 | CCR2 (0.34) | CHRNB2CHRNB4CHRNA4TGFBR1 | |
| SCHEMBL11278512 | 0.89 | DPP7 (0.35) | CHRNB2CHRNB4CHRNA4TGFBR1 | |
| SCHEMBL1903516 | 0.82 | CHRNB2 (0.59) | CHRNB2CHRNB4CHRNA4ANPEPRNPEP | |
| SCHEMBL2467198 | 0.82 | TGFBR1 (0.34) | TGFBR1RXFP1 | |
| SCHEMBL18573257 | 0.82 | CHRNB2 (0.44) | CHRNB2CHRNB4CHRNA4CHRNA3 | |
| SCHEMBL30639002 | 0.80 | CHRNB2 (0.46) | CHRNB2CHRNB4CHRNA4ANPEPRNPEP | |
| SCHEMBL3235398 | 0.77 | ANPEP (0.52) | ANPEPRNPEPDNPEPTGFBR1SMN1; SMN2 | |
| Sulfuric Acid SCHEMBL9442217 | 0.77 | TGFBR1 (0.34) | TGFBR1 | |
| SCHEMBL157717 | 0.76 | ALDH1A1 (0.45) | CHRNB2CHRNB4CHRNA4ANPEPRNPEP | |
| SCHEMBL14413834 | 0.76 | TGFBR1 (0.37) | CHRNB2CHRNB4CHRNA4ANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6770293-B2 | FOR USE IN COSMETIC APPLICATIONS, APPLICATIONS IN CROP PROTECTION, FOR CLEANERS OR FOOD SUPPLEMENTS | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-03 | — | — | US | disclosed |
| US-20020119169-A1 | Soft capsules comprising polymers of vinyl esters and polyethers, the use and production thereof | BASF AKTIENGESELLSCHAFT (DE) | 2002-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020119169-A1 | Soft capsules comprising polymers of vinyl esters and polyethers, the use and production thereof | RPS4Y1, PUF60, ELOVL3 | CHRNB2 4858/4885CHRNB4 4821/4885CHRNA4 4737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.